128 related articles for article (PubMed ID: 30987576)
1. LHRH Targeted Chonderosomes of Mitomycin C in Breast Cancer: An
Varshosaz J; Sarrami N; Aghaei M; Aliomrani M; Azizi R
Anticancer Agents Med Chem; 2019; 19(11):1405-1417. PubMed ID: 30987576
[TBL] [Abstract][Full Text] [Related]
2. Loading mitomycin C inside long circulating hyaluronan targeted nano-liposomes increases its antitumor activity in three mice tumor models.
Peer D; Margalit R
Int J Cancer; 2004 Feb; 108(5):780-9. PubMed ID: 14696107
[TBL] [Abstract][Full Text] [Related]
3. Pt-Mal-LHRH, a Newly Synthesized Compound Attenuating Breast Cancer Tumor Growth and Metastasis by Targeting Overexpression of the LHRH Receptor.
Calderon LE; Keeling JK; Rollins J; Black CA; Collins K; Arnold N; Vance DE; Ndinguri MW
Bioconjug Chem; 2017 Feb; 28(2):461-470. PubMed ID: 27997127
[TBL] [Abstract][Full Text] [Related]
4. Targeted delivery of cisplatin by LHRH-peptide conjugated dextran nanoparticles suppresses breast cancer growth and metastasis.
Li M; Tang Z; Zhang Y; Lv S; Li Q; Chen X
Acta Biomater; 2015 May; 18():132-43. PubMed ID: 25735801
[TBL] [Abstract][Full Text] [Related]
5. Application of luteinizing hormone-releasing hormone-ferrosoferric oxide nanoparticles in targeted imaging of breast tumors.
Nian D; Shi P; Sun J; Ren L; Hao X; Han J
J Int Med Res; 2019 Apr; 47(4):1749-1757. PubMed ID: 30880516
[TBL] [Abstract][Full Text] [Related]
6. The in vivo antitumor activity of LHRH targeted methotrexate-human serum albumin nanoparticles in 4T1 tumor-bearing Balb/c mice.
Taheri A; Dinarvand R; Ahadi F; Khorramizadeh MR; Atyabi F
Int J Pharm; 2012 Jul; 431(1-2):183-9. PubMed ID: 22531853
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic efficacy of a lipid-based prodrug of mitomycin C in pegylated liposomes: studies with human gastro-entero-pancreatic ectopic tumor models.
Gabizon A; Amitay Y; Tzemach D; Gorin J; Shmeeda H; Zalipsky S
J Control Release; 2012 Jun; 160(2):245-53. PubMed ID: 22134116
[TBL] [Abstract][Full Text] [Related]
8. Saporin-loaded CD44 and EGFR dual-targeted nanogels for potent inhibition of metastatic breast cancer in vivo.
Chen J; He H; Deng C; Yin L; Zhong Z
Int J Pharm; 2019 Apr; 560():57-64. PubMed ID: 30699364
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effect of folate-targeted and PEGylated phytosomes loaded with a mitomycin C-soybean phosphatidyhlcholine complex.
Li Y; Wu H; Jia M; Cui F; Lin J; Yang X; Wang Y; Dai L; Hou Z
Mol Pharm; 2014 Sep; 11(9):3017-26. PubMed ID: 25054963
[TBL] [Abstract][Full Text] [Related]
10. Potentiation of apoptosis by flavopiridol in mitomycin-C-treated gastric and breast cancer cells.
Schwartz GK; Farsi K; Maslak P; Kelsen DP; Spriggs D
Clin Cancer Res; 1997 Sep; 3(9):1467-72. PubMed ID: 9815832
[TBL] [Abstract][Full Text] [Related]
11. Folate receptor-targeted multimodal polymersomes for delivery of quantum dots and doxorubicin to breast adenocarcinoma: In vitro and in vivo evaluation.
Alibolandi M; Abnous K; Sadeghi F; Hosseinkhani H; Ramezani M; Hadizadeh F
Int J Pharm; 2016 Mar; 500(1-2):162-78. PubMed ID: 26802496
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronan-grafted particle clusters loaded with Mitomycin C as selective nanovectors for primary head and neck cancers.
Bachar G; Cohen K; Hod R; Feinmesser R; Mizrachi A; Shpitzer T; Katz O; Peer D
Biomaterials; 2011 Jul; 32(21):4840-8. PubMed ID: 21482433
[TBL] [Abstract][Full Text] [Related]
13. Phytosomes loaded with mitomycin C-soybean phosphatidylcholine complex developed for drug delivery.
Hou Z; Li Y; Huang Y; Zhou C; Lin J; Wang Y; Cui F; Zhou S; Jia M; Ye S; Zhang Q
Mol Pharm; 2013 Jan; 10(1):90-101. PubMed ID: 23194396
[TBL] [Abstract][Full Text] [Related]
14. In Vivo Evaluation of Reduction-Responsive Alendronate-Hyaluronan-Curcumin Polymer-Drug Conjugates for Targeted Therapy of Bone Metastatic Breast Cancer.
Wang K; Guo C; Dong X; Yu Y; Wang B; Liu W; Chen D
Mol Pharm; 2018 Jul; 15(7):2764-2769. PubMed ID: 29792799
[TBL] [Abstract][Full Text] [Related]
15. LHRH-conjugated micelles for targeted delivery of antiandrogen to treat advanced prostate cancer.
Wen D; Chitkara D; Wu H; Danquah M; Patil R; Miller DD; Mahato RI
Pharm Res; 2014 Oct; 31(10):2784-95. PubMed ID: 24789451
[TBL] [Abstract][Full Text] [Related]
16. CD44-tropic polymeric nanocarrier for breast cancer targeted rapamycin chemotherapy.
Zhao Y; Zhang T; Duan S; Davies NM; Forrest ML
Nanomedicine; 2014 Aug; 10(6):1221-30. PubMed ID: 24637218
[TBL] [Abstract][Full Text] [Related]
17. Development of both methotrexate and mitomycin C loaded PEGylated chitosan nanoparticles for targeted drug codelivery and synergistic anticancer effect.
Jia M; Li Y; Yang X; Huang Y; Wu H; Huang Y; Lin J; Li Y; Hou Z; Zhang Q
ACS Appl Mater Interfaces; 2014 Jul; 6(14):11413-23. PubMed ID: 24977925
[TBL] [Abstract][Full Text] [Related]
18. Curcumin enhanced antiproliferative effect of mitomycin C in human breast cancer MCF-7 cells in vitro and in vivo.
Zhou QM; Wang XF; Liu XJ; Zhang H; Lu YY; Su SB
Acta Pharmacol Sin; 2011 Nov; 32(11):1402-10. PubMed ID: 21986579
[TBL] [Abstract][Full Text] [Related]
19. [Intraperitoneal chemotherapy with mitomycin C bound to activated carbon nanoparticles for nude mice bearing human gastric carcinoma].
Qu QL; Zhang YG; Yang LZ; Sun L
Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):257-60. PubMed ID: 16875622
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxicity and apoptosis enhancement in breast and cervical cancer cells upon coadministration of mitomycin C and essential oils in nanoemulsion formulations.
Al-Otaibi WA; Alkhatib MH; Wali AN
Biomed Pharmacother; 2018 Oct; 106():946-955. PubMed ID: 30119267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
